Home › Gastrointestinal Stromal Tumors › Tennessee › Nashville
Gastrointestinal Stromal Tumors clinical trials in Nashville, TN
5 studies for Gastrointestinal Stromal Tumors are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
- SCRI Oncology Partners, Nashville
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Nashville
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- SCRI - TriStar Medical Group Children's Specialists, Nashville
- SCRI Oncology Partners, Nashville
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
RecruitingPhase 1
- Sarah Cannon Research Institute, Nashville
- Vanderbilt University Medical Center, Nashville
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
RecruitingPhase 1/2
- Vanderbilt University-Ingram Cancer Center, Nashville
Gastrointestinal Stromal Tumors trials in other cities
- Miami, FL8 studies
- Boston, MA7 studies
- New York City, NY7 studies
- Houston, TX6 studies
- Philadelphia, PA6 studies
- San Diego, CA5 studies
- Portland, OR5 studies
- Omaha, NE5 studies
- Los Angeles, CA4 studies
- Ann Arbor, MI4 studies
- Durham, NC4 studies
- Rochester, MN4 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.